Phase II to III studies are delivered through an embedded model that connects community based medical practices, EMR based pre screening and centralized operations under one coordinated structure.
Alongside outpatient Phase II to III studies, FOMAT also operates a dedicated early phase unit for first-in-human studies, intensive safety monitoring, and complex PK and PD work.
FOMAT runs outpatient studies across multiple specialties, including
- Allergy and immunology
- Cardiology
- Dermatology
- Endocrinology and metabolic disorders
- Family medicine and internal medicine
- Gastroenterology and hepatology
- Infectious diseases and vaccines
- Nephrology
- Neurology
- Oncology
- Ophthalmology and retina
- Pediatrics and adolescents
- Rheumatology
- Urology
- Wound care and related specialties